Advancing methods to better cryopreserve organs will reimagine pressing medical needs, like organ transplantation, and help ensure humanity’s well-being far into the future. Lorentz Bio is an early stage, well-funded deeptech startup that was spun out of the Longevity Fund working to make fundamental advances in organ cryopreservation.